TY  - CHAP
M1  - Book, Section
TI  - Chapter 50. Liver Transplantation
A1  - Qamar, Amir A.
A2  - Greenberger, Norton J.
A2  - Blumberg, Richard S.
A2  - Burakoff, Robert
PY  - 2012
T2  - CURRENT Diagnosis & Treatment: Gastroenterology, Hepatology, & Endoscopy, 2e
AB  - Hepatitis  C  and  hepatocellular  carcinoma  are  among  the  leading  indications  for  liver  transplantation  in  the  United  States.Thorough  medical,  psychiatric,  and  social  evaluation  is  required  prior  to  listing  patients  for  transplantation.The  Model  for  End-Stage  Liver  Disease  (MELD)  score  is  widely  used  for  prioritizing  patients  on  the  transplant  waiting  list.Liver  biopsy  is  needed  to  confirm  the  diagnosis  of  acute  rejection,  which  is  common  and  occurs  in  up  to  60%  of  patients.Medical  and  surgical  complications  after  transplantation  can  occur  immediately  or  years  later.Biliary  strictures  and  leaks  occur  in  15%  of  patients  after  transplantation.Long-term  immunosuppression,  particularly  with  calcineurin  inhibitors,  is  associated  with  an  increased  risk  of  renal  failure.  
SN  - 
PB  - The McGraw-Hill Companies
CY  - New York, NY
Y2  - 2024/04/18
UR  - accessmedicine.mhmedical.com/content.aspx?aid=55961794
ER  -